NCT02087722View on ClinicalTrials.gov

Efficacy and Safety of KI1001 in the Treatment of ≥ 55 Years Old Insomnia Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Sleep Initiation and Maintenance Disorders
Interventions
DRUG

KI1001

DRUG

Placebo

Trial Locations (4)

442-723

St. Vincent Hospital, Suwon

130-709

St. Paul's Hospital, Seoul

134-727

Kyung Hee University Hospital at Gangdong, Seoul

143-729

Konkuk University Medical Center, Seoul

Sponsors
All Listed Sponsors
collaborator

Neurim Pharmaceuticals Ltd.

INDUSTRY

lead

Kuhnil Pharmaceutical Co., Ltd.

INDUSTRY

NCT02087722 - Efficacy and Safety of KI1001 in the Treatment of ≥ 55 Years Old Insomnia Patients | Biotech Hunter | Biotech Hunter